Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates

British Journal of Nutrition

Volumn 106, Issue 12, 2011, Pages 1779-1791

  Yan, Huiqin ^a   Zhu, Yu ^a   Liu, Boning ^a   Wu, Heng ^a   Li, Yongwen ^a   Wu, Xiang ^a   Zhou, Qinghua ^a   Xu, Ke ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Isothiocyanates; Lung cancer; Mitogen activated protein kinase

Indexed keywords

ACETYLCYSTEINE; BENZYL ISOTHIOCYANATE; CASPASE 3; CYCLIN B1; CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENETHYL ISOTHIOCYANATE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ACETYLCYSTEINE; ANTIOXIDANTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CYCLIN B1; GENE EXPRESSION; HUMANS; ISOTHIOCYANATES; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; NEOPLASM METASTASIS; TRANSCRIPTION FACTOR AP-1;

EID: 82555189785     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511002315     Document Type: Article

References (45)

1. Ferlay J, Shin HR, Bray F, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 2893-2917.
2. Rudd RM, Gower NH, Spiro SG, et al. (2005) Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. J Clin Oncol 23, 142-153. (Pubitemid 41702633)
3. Martoni A, Marino A, Sperandi F, et al. (2005) Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. Eur J Cancer 41, 81-92. (Pubitemid 40029660)
4. Lam TK, Gallicchio L, Lindsley K, et al. (2009) Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev 18, 184-195.
5. Wu X, Zhou QH & Xu K (2009) Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol Sin 30, 501-512.
6. Xu K & Thornalley PJ (2001) Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. Br J Cancer 84, 670-673. (Pubitemid 32239001)
7. Xu K & Thornalley PJ (2000) Studies on the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. Biochem Pharmacol 60, 221-231. (Pubitemid 30312950)
8. Gong A, He M, Krishna Vanaja D, et al. (2009) Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol Nutr Food Res 53, 878-886.
9. Kang L, Ding L & Wang ZY (2009) Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells. Oncol Rep 21, 185-192.
10. Mi L, Gan N, Cheema A, et al. (2009) Cancer preventive isothiocyanates induce selective degradation of cellular alpha-and beta-tubulins by proteasomes. J Biol Chem 284, 17039-17051.
11. Mukherjee S, Dey S, Bhattacharya RK, et al. (2009) Isothio-cyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells. Mol Cell Biochem 330, 9-22.
12. Prawan A, Saw CL, Khor TO, et al. (2009) Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling. Chem Biol Interact 179, 202-211.
13. Xiao D & Singh SV (2007) Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res 67, 2239-2246. (Pubitemid 46424243)
14. Thejass P & Kuttan G (2007) Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate. Integr Cancer Ther 6, 389-399. (Pubitemid 350136014)
15. Thejass P & Kuttan G (2007) Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angio-genesis by downregulating nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) production. Nitric Oxide 16, 247-257. (Pubitemid 46149387)
16. Hwang ES & Lee HJ (2008) Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells. Food Chem Toxicol 46, 2358-2364.
17. Lai KC, Huang AC, Hsu SC, et al. (2010) Benzyl isothiocya-nate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloprotei-nase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J Agric Food Chem 58, 2935-2942.
18. Hunakova L, Sedlakova O, Cholujova D, et al. (2009) Modulation of markers associated with aggressive pheno-type in MDA-MB-231 breast carcinoma cells by sulfora-phane. Neoplasma 56, 548-556.
19. Wu X, Zhu Y, Yan H, et al. (2010) Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer 10, 269.
20. Zhou Q, Wang Y, Che G, et al. (2003) Establishment and their biological characteristics of clonal cell subpopulations (NL9980 and L9981) from a human lung large cell carcinoma cell line (WCQH29801). Chin J Lung Canc 6, 464-468. (Pubitemid 38029281)
21. Xu K, Guidez F, Glasow A, et al. (2005) Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated core-pressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer Res 65, 7856-7865. (Pubitemid 41297262)
22. Gupta GP & Massague J (2006) Cancer metastasis: building a framework. Cell 127, 679-695. (Pubitemid 44781029)
23. Yu R, Mandlekar S, Harvey KJ, et al. (1998) Chemopreven-tive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res 58, 402-408. (Pubitemid 28087397)
24. Hu R, Kim BR, Chen C, et al. (2003) The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24, 1361-1367. (Pubitemid 37038826)
25. Xiao D, Srivastava SK, Lew KL, et al. (2003) Allyl isothiocya-nate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 24, 891-897. (Pubitemid 36748905)
26. Miyoshi N, Uchida K, Osawa T, et al. (2004) A link between benzyl isothiocyanate-induced cell cycle arrest and apopto-sis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Res 64, 2134-2142. (Pubitemid 38339464)
27. Miyoshi N, Uchida K, Osawa T, et al. (2004) Benzyl isothio-cyanate modifies expression of the G2/M arrest-related genes. Biofactors 21, 23-26. (Pubitemid 40921821)
28. Inamdar GS, Madhunapantula SV & Robertson GP (2010) Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail. Biochem Pharmacol 80, 624-637.
29. Satyan KS, Swamy N, Dizon DS, et al. (2006) Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. Gynecol Oncol 103, 261-270. (Pubitemid 44374696)
30. Shaulian E & Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4, E131-E136. (Pubitemid 34521026)
31. Oya M, Takayanagi A, Horiguchi A, et al. (2003) Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 24, 377-384. (Pubitemid 36432631)
32. Xu C, Shen G, Yuan X, et al. (2006) ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 27, 437-445. (Pubitemid 43372873)
33. Yao S, Zhang Y & Li J (2006) c-jun/AP-1 activation does not affect the antiproliferative activity of phenethyl isothiocya-nate, a cruciferous vegetable-derived cancer chemopreven-tive agent. Mol Carcinog 45, 605-612. (Pubitemid 44205100)
34. Jeong WS, Kim IW, Hu R, et al. (2004) Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line. Pharm Res 21, 649-660. (Pubitemid 38457288)
35. Shen G, Xu C, Chen C, et al. (2006) p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother Pharmacol 57, 317-327.
36. Batra S, Sahu RP, Kandala PK, et al. (2010) Benzyl isothiocya-nate- mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells. Mol Cancer Ther 9, 1596-1608.
37. Sun Y & Rigas B (2008) The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res 68, 8269-8277.
38. Trachootham D, Zhang H, Zhang W, et al. (2008) Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 112, 1912-1922.
39. Xiao D, Powolny AA & Singh SV (2008) Benzyl isothiocya-nate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J Biol Chem 283, 30151-30163.
40. Sahu RP, Zhang R, Batra S, et al. (2009) Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells. Carcinogenesis 30, 1744-1753.
41. Faustman D & Davis M (2010) TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov 9, 482-493.
42. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. (2010) Negative regulation of TLR4 via targeting of the proinflam-matory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11, 141-147.
43. King FW, Fong S, Griffin C, et al. (2009) Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress. PLoS One 4, e7283.
44. Satomi Y & Nishino H (2009) Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim Biophys Acta 1790, 260-266.
45. Le XF, Arachchige-Don AS, Mao W, et al. (2007) Roles of human epidermal growth factor receptor 2, c-jun NH2-term-inal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells. Mol Cancer Ther 6, 2843-2857. (Pubitemid 350214268)